Skip to main content
. 2020 Apr 3;8:129. doi: 10.3389/fped.2020.00129

Figure 2.

Figure 2

Comparison of M2 macrophage marker mRNA expression fold change by between healthy controls and patients with KD. HC, Healthy controls (18 patients); KD1, acute Kawasaki disease 24 h prior to IVIG therapy (18 patients); KD2, resolving Kawasaki disease 21 days after IVIG therapy (18 patients). An asterisk denotes a p < 0.05. Data are expressed as mean ± standard error.